IL115276A - History of a, 4, 35, 3 tetrahydrooxazolo) a-3,4 (quinoline-1 - ON converted in column 7 Preparation and pharmaceutical preparations containing them - Google Patents
History of a, 4, 35, 3 tetrahydrooxazolo) a-3,4 (quinoline-1 - ON converted in column 7 Preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL115276A IL115276A IL11527695A IL11527695A IL115276A IL 115276 A IL115276 A IL 115276A IL 11527695 A IL11527695 A IL 11527695A IL 11527695 A IL11527695 A IL 11527695A IL 115276 A IL115276 A IL 115276A
- Authority
- IL
- Israel
- Prior art keywords
- quinolin
- oxazolo
- tetrahydro
- formula
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9410600A FR2724171B1 (fr) | 1994-09-05 | 1994-09-05 | Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL115276A0 IL115276A0 (en) | 1996-01-19 |
| IL115276A true IL115276A (en) | 1998-12-06 |
Family
ID=9466686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11527695A IL115276A (en) | 1994-09-05 | 1995-09-12 | History of a, 4, 35, 3 tetrahydrooxazolo) a-3,4 (quinoline-1 - ON converted in column 7 Preparation and pharmaceutical preparations containing them |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5641785A (de) |
| EP (1) | EP0699680B1 (de) |
| JP (1) | JP4225585B2 (de) |
| KR (1) | KR100392523B1 (de) |
| CN (1) | CN1055472C (de) |
| AT (1) | ATE190311T1 (de) |
| AU (1) | AU687591B2 (de) |
| CA (1) | CA2157427C (de) |
| CZ (1) | CZ286128B6 (de) |
| DE (1) | DE69515402T2 (de) |
| DK (1) | DK0699680T3 (de) |
| ES (1) | ES2145886T3 (de) |
| FI (1) | FI110945B (de) |
| FR (1) | FR2724171B1 (de) |
| GR (1) | GR3033554T3 (de) |
| HK (1) | HK1013652A1 (de) |
| HU (1) | HU218587B (de) |
| IL (1) | IL115276A (de) |
| NO (1) | NO306617B1 (de) |
| NZ (1) | NZ272920A (de) |
| PL (1) | PL184412B1 (de) |
| PT (1) | PT699680E (de) |
| RU (1) | RU2141482C1 (de) |
| SI (1) | SI0699680T1 (de) |
| SK (1) | SK281867B6 (de) |
| TW (1) | TW356467B (de) |
| UA (1) | UA41916C2 (de) |
| ZA (1) | ZA957414B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1078632A1 (de) * | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Verwendung von Monoamin Oxydase Inhibitoren zu Herstellung eines Medikaments zur Behandlung der Fettleibigkeit |
| WO2005090309A1 (en) * | 2004-03-12 | 2005-09-29 | Wyeth | 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection |
| AU2008226649B2 (en) * | 2007-03-09 | 2013-08-01 | Sanofi | Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof |
| RU2366430C2 (ru) | 2007-05-23 | 2009-09-10 | Виктор Иванович Рощин | Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция |
| AR078171A1 (es) | 2009-09-15 | 2011-10-19 | Sanofi Aventis | Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas |
| CN105949120B (zh) | 2016-05-27 | 2018-07-24 | 广东工业大学 | 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2624861B1 (fr) * | 1987-12-21 | 1990-06-01 | Delalande Sa | Carbamates tricycliques, leur procede de preparation et leur application en therapeutique |
| ES2013391A6 (es) * | 1989-02-08 | 1990-05-01 | Consejo Superior Investigacion | Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles. |
| JPH04295470A (ja) * | 1991-03-22 | 1992-10-20 | Wakamoto Pharmaceut Co Ltd | モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法 |
-
1994
- 1994-09-05 FR FR9410600A patent/FR2724171B1/fr not_active Expired - Lifetime
-
1995
- 1995-09-01 ES ES95401989T patent/ES2145886T3/es not_active Expired - Lifetime
- 1995-09-01 US US08/523,508 patent/US5641785A/en not_active Expired - Lifetime
- 1995-09-01 EP EP95401989A patent/EP0699680B1/de not_active Expired - Lifetime
- 1995-09-01 PT PT95401989T patent/PT699680E/pt unknown
- 1995-09-01 DK DK95401989T patent/DK0699680T3/da active
- 1995-09-01 AT AT95401989T patent/ATE190311T1/de active
- 1995-09-01 SI SI9530413T patent/SI0699680T1/xx unknown
- 1995-09-01 DE DE69515402T patent/DE69515402T2/de not_active Expired - Lifetime
- 1995-09-01 CA CA2157427A patent/CA2157427C/en not_active Expired - Lifetime
- 1995-09-02 TW TW084109192A patent/TW356467B/zh not_active IP Right Cessation
- 1995-09-04 HU HU9502578A patent/HU218587B/hu unknown
- 1995-09-04 NZ NZ272920A patent/NZ272920A/en not_active IP Right Cessation
- 1995-09-04 JP JP22646295A patent/JP4225585B2/ja not_active Expired - Lifetime
- 1995-09-04 PL PL95310273A patent/PL184412B1/pl unknown
- 1995-09-04 AU AU30415/95A patent/AU687591B2/en not_active Expired
- 1995-09-04 CZ CZ19952262A patent/CZ286128B6/cs not_active IP Right Cessation
- 1995-09-04 FI FI954141A patent/FI110945B/fi not_active IP Right Cessation
- 1995-09-04 RU RU95114741A patent/RU2141482C1/ru active
- 1995-09-04 ZA ZA957414A patent/ZA957414B/xx unknown
- 1995-09-04 SK SK1089-95A patent/SK281867B6/sk not_active IP Right Cessation
- 1995-09-04 NO NO953458A patent/NO306617B1/no not_active IP Right Cessation
- 1995-09-04 KR KR1019950028714A patent/KR100392523B1/ko not_active IP Right Cessation
- 1995-09-04 UA UA95094019A patent/UA41916C2/uk unknown
- 1995-09-04 CN CN95117143A patent/CN1055472C/zh not_active Expired - Lifetime
- 1995-09-12 IL IL11527695A patent/IL115276A/en not_active IP Right Cessation
-
1998
- 1998-12-23 HK HK98114972A patent/HK1013652A1/xx not_active IP Right Cessation
-
2000
- 2000-05-31 GR GR20000401246T patent/GR3033554T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2544856C2 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| US11273168B2 (en) | Methods of treating anxiety by administering a substituted quinolone | |
| KR101369126B1 (ko) | 탄소환 ｇｌｙｔ1 수용체 길항제 | |
| IL115276A (en) | History of a, 4, 35, 3 tetrahydrooxazolo) a-3,4 (quinoline-1 - ON converted in column 7 Preparation and pharmaceutical preparations containing them | |
| KR20150007352A (ko) | Kat ii 억제제로서 삼환 화합물 | |
| JP4565747B2 (ja) | テトラヒドロイソキノリンアルカノール誘導体及びそれを含む薬学的組成物 | |
| TW201348215A (zh) | 雜環化合物 | |
| US5955471A (en) | Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions containing same | |
| WO2024035757A2 (en) | Tryptamines and methods of treating mood disorders | |
| KR20010108167A (ko) | 테트라히드로이소퀴놀린알칸올 유도체 및 이를 함유하는약학적 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |